Literature DB >> 19558186

Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library.

Teruhiko Matsubara1, Machiko Sumi, Hiroyuki Kubota, Takao Taki, Yoshio Okahata, Toshinori Sato.   

Abstract

Influenza virus hemagglutinin recognizes sialyloligosaccharides of glycoproteins and glycolipids as cell surface receptors in the initial stage of the infection process. We demonstrate that pentadecapeptides that bind to a sialylgalactose structure (Neu5Ac-Gal) inhibited the infection of cells by influenza virus. The pentadecapeptides were identified through affinity selection from a phage-displayed random peptide library using a monolayer of the ganglioside Neu5Acalpha2-3Galbeta1-4Glcbeta1-1'Cer (GM3). The peptides were found to have affinity for GM3, and alanine scanning showed seven amino acid residues that contribute to carbohydrate recognition. The binding of peptides to the cell surface was significantly inhibited in the presence of sialic acid or by the digestion of cell surface sialyl residues by neuraminidase. Plaque assays indicated that a molecular assembly of alkylated peptides inhibited the infection of Madin-Darby canine kidney cells by influenza virus. Carbohydrate-binding peptides that inhibit carbohydrate-virus interaction showed inhibitory activity. These results may lead to a new approach to the design of antiviral drugs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19558186     DOI: 10.1021/jm801570y

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  22 in total

1.  Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases.

Authors:  Gero L Becker; Yinghui Lu; Kornelia Hardes; Boris Strehlow; Christine Levesque; Iris Lindberg; Kirsten Sandvig; Udo Bakowsky; Robert Day; Wolfgang Garten; Torsten Steinmetzer
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

2.  Effects of macromolecular crowding on the inhibition of virus assembly and virus-cell receptor recognition.

Authors:  Verónica Rincón; Rebeca Bocanegra; Alicia Rodríguez-Huete; Germán Rivas; Mauricio G Mateu
Journal:  Biophys J       Date:  2011-02-02       Impact factor: 4.033

3.  Chemical Synthesis and In Vitro Evaluation of a Phage Display-Derived Peptide Active against Infectious Salmon Anemia Virus.

Authors:  Nicolás Ojeda; Constanza Cárdenas; Fanny Guzmán; Sergio H Marshall
Journal:  Appl Environ Microbiol       Date:  2016-04-04       Impact factor: 4.792

4.  Highly sensitive detection of influenza virus by boron-doped diamond electrode terminated with sialic acid-mimic peptide.

Authors:  Teruhiko Matsubara; Michiko Ujie; Takashi Yamamoto; Miku Akahori; Yasuaki Einaga; Toshinori Sato
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-25       Impact factor: 11.205

5.  Novel hemagglutinin-based influenza virus inhibitors.

Authors:  Xintian Shen; Xuanxuan Zhang; Shuwen Liu
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

6.  Nanoscale pathogens treated with nanomaterial-like peptides: a platform technology appropriate for future pandemics.

Authors:  Alaa F Nahhas; Alrayan F Nahhas; Thomas J Webster
Journal:  Nanomedicine (Lond)       Date:  2021-05-14       Impact factor: 5.307

7.  Computer-based de novo designs of tripeptides as novel neuraminidase inhibitors.

Authors:  Zhiwei Yang; Gang Yang; Yuangang Zu; Yujie Fu; Lijun Zhou
Journal:  Int J Mol Sci       Date:  2010-12-01       Impact factor: 5.923

Review 8.  Anti-Angiogenic Property of Free Human Oligosaccharides.

Authors:  Boram Bae; Haeun Kim; Hyerin Park; Young Jun Koh; Sung-Jin Bae; Ki-Tae Ha
Journal:  Biomolecules       Date:  2021-05-21

Review 9.  Discovery of Antivirals Using Phage Display.

Authors:  Esen Sokullu; Marie-Soleil Gauthier; Benoit Coulombe
Journal:  Viruses       Date:  2021-06-10       Impact factor: 5.048

Review 10.  Influenza A virus entry inhibitors targeting the hemagglutinin.

Authors:  Jie Yang; Minmin Li; Xintian Shen; Shuwen Liu
Journal:  Viruses       Date:  2013-01-22       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.